Analyst Reco. ChampionX Corporation

Equities

CHX

US15872M1045

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
33.6 ^USD	+0.15%		-3.61%	+15.03%

04-24	ChampionX Q1 Adjusted EPS Increases, Revenue Declines	MT
04-24	Earnings Flash (CHX) CHAMPIONX CORPORATION Posts Q1 Revenue $922.1M, vs. Street Est of $921.6M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Raises ChampionX's Price Target to $40 From $32, Maintains Neutral Rating	04-08	MT
Barclays Raises Price Target on ChampionX to $51 From $39, Maintains Overweight Rating	04-04	MT
RBC Raises Price Target on Schlumberger to $69 From $66 Amid ChampionX Deal, Keeps Outperform Rating	04-03	MT
ChampionX Insider Sold Shares Worth $978,408, According to a Recent SEC Filing	04-01	MT
Piper Sandler Downgrades ChampionX to Neutral From Overweight, Adjusts Price Target to $32 From $38	01-08	MT
Goldman Sachs Cuts Price Target on ChampionX to $32 From $37, Maintains Neutral Rating	11-14	MT
Piper Sandler Adjusts Price Target on ChampionX to $38 From $42, Maintains Overweight Rating	27/10/23	MT
Barclays Upgrades ChampionX to Overweight Equal-Weight, Raises Price Target to $44 From $33	17/10/23	MT
Capital One Initiates ChampionX With Overweight Rating, $40 Price Target	14/07/23	MT
Citigroup Trims Price Target on ChampionX to $40 From $41, Maintains Buy Rating	05/04/23	MT
Goldman Sachs Adjusts ChampionX's Price Target to $32 From $21, Keeps Neutral Rating	02/11/22	MT
Citigroup Adjusts ChampionX Price Target to $34 From $30, Maintains Buy Rating	01/11/22	MT
Barclays Downgrades ChampionX to Equalweight From Overweight, Reduces Price Target to $28 From $38	06/10/22	MT
ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings...	25/08/22
Benchmark Starts ChampionX at Buy With $32 Price Target	25/08/22	MT
BofA Securities Upgrades ChampionX to Buy From Neutral; Price Target is $22	15/07/22	MT
Goldman Sachs Lowers Price Target for ChampionX to $21 From $26, Maintains Neutral Rating	12/07/22	MT
S&P Revises ChampionX Corp. Outlook To Positive On Improving Financial Measures, Ratings Affirmed	25/05/22	MT
Barclays Adjusts ChampionX's Price Target to $38 from $33, Keeps Overweight Rating	02/05/22	MT
Piper Sandler Lifts ChampionX to Overweight From Neutral, Price Target to $30 From $28	11/04/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. ChampionX Corporation

Equities

CHX

US15872M1045

Analyst Reco.

Filters